Contreras F, Fouillioux C, Bolívar A, Simonovis N, Hernández-Hernández R, Armas-Hernandez M, Velasco M (2002). „Dopamine, hypertension and obesity”. J Hum Hypertens16 Suppl 1: S13–7. DOI:10.1038/sj.jhh.1001334. PMID11986886.
Hurley MJ, Jenner P (2006). „What has been learnt from study of dopamine receptors in Parkinson's disease?”. Pharmacol Ther.111 (3): 715. DOI:10.1016/j.pharmthera.2005.12.001. PMID16458973.
Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G (January 1998). „D3 dopamine receptor mRNA is widely expressed in the human brain”. Brain Res.779 (1-2): 58–74. DOI:10.1016/S0006-8993(97)01078-0. PMID9473588.
Manor I, Tyano S, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP (2002). „The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA)”. Mol. Psychiatry7 (7): 790–4. DOI:10.1038/sj.mp.4001078. PMID12192625.
Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF (July 2004). „Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5”. Mol. Psychiatry9 (7): 711–7. DOI:10.1038/sj.mp.4001466. PMID14699430.
Contreras F, Fouillioux C, Bolívar A, Simonovis N, Hernández-Hernández R, Armas-Hernandez M, Velasco M (2002). „Dopamine, hypertension and obesity”. J Hum Hypertens16 Suppl 1: S13–7. DOI:10.1038/sj.jhh.1001334. PMID11986886.
Hurley MJ, Jenner P (2006). „What has been learnt from study of dopamine receptors in Parkinson's disease?”. Pharmacol Ther.111 (3): 715. DOI:10.1016/j.pharmthera.2005.12.001. PMID16458973.
Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G (January 1998). „D3 dopamine receptor mRNA is widely expressed in the human brain”. Brain Res.779 (1-2): 58–74. DOI:10.1016/S0006-8993(97)01078-0. PMID9473588.
Manor I, Tyano S, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP (2002). „The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA)”. Mol. Psychiatry7 (7): 790–4. DOI:10.1038/sj.mp.4001078. PMID12192625.
Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF (July 2004). „Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5”. Mol. Psychiatry9 (7): 711–7. DOI:10.1038/sj.mp.4001466. PMID14699430.